NIPPON KINZOKU “Eco-Product” Series - Vol. 2, Introducing “NK-301ZF”: A Breakthrough Material Combining High Strength and High Ductility
- Challenging Limits: A Material that Achieves the Balance of Two Contradictory Properties -
NIPPON KINZOKU CO., LTD. (TOKYO: 5491) (Headquarters: Minato-ku, Tokyo) is proud to introduce “NK-301ZF”, spring-use stainless steel that achieves both excellent processability and high strength within the chemical composition range of SUS301 (JIS), as part of its environmentally conscious “Eco-Product” series. This material has been widely adopted in various industries, including the automotive, electronic components, and semiconductors sectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250526260185/en/
NK-301ZF combines high strength with high ductility, enabling both weight reduction of parts and simplification of manufacturing processes. These characteristics have led to its adoption in a wide range of applications, including smartphone components, diaphragm, and flat spiral spring.
NK-301ZF combines high strength with high ductility, enabling both weight reduction of parts and simplification of manufacturing processes. This contributes to improved energy efficiency and reduced environmental impact throughout the customer's entire manufacturing process. Additionally, its enhanced design flexibility allows for optimization of shapes and specifications, leading to improved processing efficiency and yield. These characteristics have led to its adoption in a wide range of applications.
At our company, NK-301ZF is designated as an “Eco-Product” based on these considerations. We are committed to sustainable manufacturing through the promotion of environmentally friendly materials, with the goal of achieving Net Zero CO₂ emissions by 2050.
This product was developed in accordance with NIPPON KINZOKU's 11th business plan, “NIPPON KINZOKU 2030”, which is focused on the key concept of “Near Net Performance" -achieving the performance required by end products through material design. Our objective is to further expand its sales in the automotive, electronic components, semiconductors, and related markets.
Features
1. Chemical Composition
The chemical composition is adjusted to meet the JIS standard range.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/Chemical-Composition.pdf
2. Mechanical Property
Compared to conventional SUS301, NK-301ZF has greater elongation, helping to prevent cracking during forming. It is also a high-strength material that can achieve a hardness level of HV580 or higher.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/Mechanical-Properties.pdf
At equivalent strength levels, it offers higher elongation and superior ductility to conventional SUS301.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/Relationship-Between-Hardness-and-Elongation.pdf
3. Fatigue Resistance, Processability
We controlled the inclusions in the steel, which significantly reduced the amount of macroscopic nonmetallic inclusions.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/Image-of-Inclusions.pdf
Consequently, we anticipate improved fatigue resistance.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/MIT-test-results.pdf
Click here for the full text.
https://www.nipponkinzoku.co.jp/assets/images/2025/05/Introducing-NK-301ZF-A-Breakthrough-Material-Combining-High-Strength-and-High-Ductility.pdf
About NIPPON KINZOKU Group
Our products have been used in a range of areas from the precision field to the construction industry. https://www.nipponkinzoku.co.jp/en/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250526260185/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release
Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,
LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release
~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut
The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release
The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the
Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release
Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom